IGF1 modifications after bariatric surgery in morbidly obese patients: Potential implications of nutritional status according to specific surgical technique

European Journal of Endocrinology

Volumn 169, Issue 5, 2013, Pages 695-703

  Pellitero, Silvia ^a   Granada, María Luisa ^a   Martínez, Eva ^a   Balibrea, Jose María ^a   Guanyabens, Elena ^a   Serra, Assumpta ^a   Moreno, Pau ^a   Navarro, Maruja ^a   Romero, Ramon ^a   Alastrué, Antonio ^a   Puig Domingo, Manel ^a  

^a HOSPITAL UNIVERSITARI GERMANS TRIAS I PUJOL   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

ALBUMIN; GHRELIN; SOMATOMEDIN BINDING PROTEIN 3; SOMATOMEDIN C;

ADULT; ARTICLE; BARIATRIC SURGERY; BODY MASS; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; MORBID OBESITY; NUTRITIONAL STATUS; PRIORITY JOURNAL; ROUX EN Y GASTRIC BYPASS; ROUX Y ANASTOMOSIS; SLEEVE GASTRECTOMY; STOMACH BYPASS; SURGICAL TECHNIQUE;

ADULT; BARIATRIC SURGERY; BODY MASS INDEX; FEMALE; GHRELIN; HOMEOSTASIS; HUMANS; HYPERTENSION; INSULIN; INSULIN RESISTANCE; INSULIN-LIKE GROWTH FACTOR BINDING PROTEIN 3; INSULIN-LIKE GROWTH FACTOR I; LIPIDS; MALE; MIDDLE AGED; NUTRITIONAL STATUS; OBESITY, MORBID; ODDS RATIO; PROSPECTIVE STUDIES; REGRESSION ANALYSIS; SERUM ALBUMIN;

EID: 84886309727     PISSN: 08044643     EISSN: 1479683X     Source Type: Journal    
DOI: 10.1530/EJE-13-0209     Document Type: Article

References (40)

1. Bessesen DH. Update on obesity. Journal of Clinical Endocrinology and Metabolism 2008 93 2027-2034. (doi:10.1210/jc.2008-0520)
2. Narayan KM, Boyle JP, Thompson TJ, Gregg EW & Williamson DF. Effect of BMI on lifetime risk for diabetes in the U.S. Diabetes Care 2007 30 1562-1566. (doi:10.2337/dc06-2544)
3. Serra A, Romero R, Lopez D, Navarro M, Esteve A, Perez N, Alastrue A & Ariza A. Renal injury in the extremely obese patients with normal renal function. Kidney International 2008 73 947-950. (doi:10.1038/sj.ki.5002796)
4. Kelestimur F, Popovic V, Leal A, Van Dam PS, Torres E, Perez Mendez LF, Greenman Y, Koppeschaar HP, Dieguez C & Casanueva FF. Effect of obesity and morbid obesity on the growth hormone (GH) secretion elicited by the combined GHRHCGHRP-6 test. Clinical Endocrinology 2006 64 667-671. (doi:10.1111/j.1365- 2265.2006.02525.x)
5. Sjöström L, Lindroos AK, Peltonen M, Torgerson J, Bouchard C, Carlsson B, Dahlgren S, Larsson B, Narbro K, Sjöström CD et al. Lifestyle, diabetes, and cardiovascular risk factors 10 years after bariatric surgery. New England Journal of Medicine 2004 351 2683-2693. (doi:10.1056/NEJMoa035622)
6. Buchwald H, Estok R, Fahrbach K, Banel D, Jensen MD, Pories WJ, Bantle JP & Sledge I. Weight and type 2 diabetes after bariatric surgery: systematic review and meta-analysis. American Journal of Medicine 2009 122 248-256. (doi:10.1016/j.amjmed.2008.09.041)
7. Serra A, Granada ML, Romero R, Bayés B, Cantón A, Bonet J, Rull M, Alastrue A & Formiguera X. The effect of bariatric surgery on adipocytokines, renal parameters and other cardiovascular risk factors in severe and very severe obesity: 1-year follow-up. Clinical Nutrition 2006 25 400-408. (doi:10.1016/j.clnu.2005.11.014)
8. Rao SR, Kini S & Tamler R. Sex hormones and bariatric surgery in men. Gender Medicine 2011 8 300-311. (doi:10.1016/j.genm.2011.05.007)
9. Rasmussen MH. Obesity, growth hormone and weight loss. Molecular and Cellular Endocrinology 2010 316 147-153. (doi:10.1016/j.mce.2009.08.017)
10. Maccario M, Valetto MR, Savio P, Aimaretti G, Baffoni C, Procopio M, Grottoli S, Oleandri SE, Arvat E & Ghigo E. Maximal secretory capacity of somatotrope cells in obesity: comparison with GH deficiency. International Journal of Obesity and Related Metabolic Disorders 1997 21 27-32. (doi:10.1038/sj.ijo.0800356)
11. Abs R, Feldt-Rasmussen U, Mattsson AF, Monson JP, Bengtsson BA, Góth MI, Wilton P & Koltowska-Häggström M. Determinants of cardiovascular risk in 2589 hypopituitary GH-deficient adults - a KIMS database analysis. European Journal of Endocrinology 2006 155 79-90. (doi:10.1530/eje.1. 02179)
12. Møller N & Jørgensen JO. Effects of growth hormone on glucose, lipid, and protein metabolism in human subjects. Endocrine Reviews 2009 30 152-177. (doi:10.1210/er.2008-0027)
13. Rasmussen MH, Juul A, Kjems LL, Skakkebaek NE & Hilsted J. Lack of stimulation of 24-hour growth hormone release by hypocaloric diet in obesity. Journal of Clinical Endocrinology and Metabolism 1995 80 796-801. (doi:10.1210/jc.80.3.796)
14. Belobrajdic DP, Frystyk J, Jeyaratnaganthan N, Espelund U, Flyvbjerg A, Clifton PM & Noakes M. Moderate energy restriction-induced weight loss affects circulating IGF levels independent of dietary composition. European Journal of Endocrinology 2010 162 1075-1082. (doi:10.1530/EJE-10-0062)
15. Rasmussen MH, Wildschiødtz G, Juul A & Hilsted J. Polysomnographic sleep, growth hormone insulin-like growth factor-I axis, leptin, and weight loss. Obesity 2008 16 1516-1521. (doi:10.1038/oby.2008.249)
16. De Marinis L, Bianchi A, Mancini A, Gentilella R, Perrelli M, Giampietro A, Porcelli T, Tilaro L, Fusco A, Valle D et al. Growth hormone secretion and leptin in morbid obesity before and after biliopancreatic diversion: relationships with insulin and body composition. Journal of Clinical Endocrinology and Metabolism 2004 89 174-180. (doi:10.1210/jc.2002-021308)
17. Edén Engström B, Burman P, Holdstock C, Ohrvall M, Sundbom M & Karlsson FA. Effects of gastric bypass on the GH/IGF-1 axis in severe obesity and a comparison with GH deficiency. European Journal of Endocrinology 2006 154 53-59. (doi:10.1530/eje.1.02069)
18. Valera Mora ME, Manco M, Capristo E, Guidone C, Iaconelli A, Gniuli D, Rosa G, Calvani M & Mingrone G. Growth hormone and ghrelin secretion in severely obese women before and after bariatric surgery. Obesity 2007 15 2012-2018. (doi:10.1038/oby.2007.240)
19. Mancini MC, Costa AP, de Melo ME, Cercato C, Giannella-Neto D, Garrido AB Jr, Rosberg S, Albertsson-Wikland K, Villares SM & Halpern A. Effect of gastric bypass on spontaneous growth hormone and ghrelin release profiles. Obesity 2006 14 383-387. (doi:10.1038/oby.2006.51)
20. Di Somma C, Angrisani L, Rota F, Savanelli MC, Cascella T, Belfiore A, Orio F, Lombardi G, Colao A & Savastano S. GH and IGF-1 deficiency are associated with reduced loss of fat mass after laparoscopic-adjustable silicone gastric banding. Clinical Endocrinology 2008 69 393-399. (doi:10.1111/j.1365- 2265.2008.03183.x)
21. Savastano S, Angrisani L, Di Somma C, Rota F, Savanelli MC, Cascella T, Orio F, Lombardi G & Colao A. Relationship between growth hormone/insulin-like growth factor-1 axis integrity and voluntary weight loss after gastric banding surgery for severe obesity. Obesity Surgery 2010 20 211-220. (doi:10.1007/s11695-009-9926-3)
22. Pardina E, Ferrer R, Baena-Fustegueras JA, Lecube A, Fort JM, Vargas V, Catalán R & Peinado-Onsurbe J. The relationships between IGF-1 and CRP, NO, leptin, and adiponectin during weight loss in the morbidly obese. Obesity Surgery 2010 20 623-632. (doi:10.1007/s11695-010-0103-5)
23. Galli G, Pinchera A, Piaggi P, Fierabracci P, Giannetti M, Querci G, Scartabelli G, Manetti L, Ceccarini G, Martinelli S et al. Serum insulin-like growth factor-1 concentrations are reduced in severely obese women and raise after weight loss induced by laparoscopic adjustable gastric banding. Obesity Surgery 2012 22 1276-1280. (doi:10.1007/s11695-012-0669-1)
24. Mittempergher F, Pata G, Crea N, Di Betta E, Vilardi A, Chiesa D & Nascimbeni R. Preoperative prediction of growth hormone (GH)/insulin-like growth factor-1 (IGF-1) axis modification and postoperative changes in candidates for bariatric surgery. Obesity Surgery 2013 23 594-601. (doi:10.1007/s11695-012- 0820-z)
25. National Institutes of Health Consensus. Gastrointestinal surgery for severe obesity Consensus Development Conference Panel. Annals of Internal Medicine 1991 115 956-961. (doi:10.7326/0003-4819-115-12-956)
26. National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III). Third Report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III) final report. Circulation 2002 106 3143-3421.
27. Mechanick JI, Kushner RF, Sugerman HJ, Gonzalez-Campoy JM, Collazo-Clavell ML, Spitz AF, Apovian CM, Livingston EH, Brolin R, Sarwer DB et al. American Association of Clinical Endocrinologists, The Obesity Society, and American Society for Metabolic & Bariatric Surgery medical guidelines for clinical practice for the perioperative nutritional, metabolic, and nonsurgical support of the bariatric surgery patient. Obesity 2009 17 S1-S70. (doi:10.1038/oby.2009.28)
28. Fobi MA, Lee H, Holness R & Cabinda D. Gastric bypass operation for obesity. World Journal of Surgery 1998 22 925-935. (doi:10.1007/s002689900496)
29. Salmon PA. Gastroplasty with distal gastric bypass: a new and more successful weight loss operation for the morbidly obese. Canadian Journal of Surgery 1988 31 111-113.
30. Cottam D, Qureshi FG, Mattar SG, Sharma S, Holover S, Bonanomi G, Ramanathan R & Schauer P. Laparoscopic sleeve gastrectomy as an initial weight-loss procedure for high-risk patients with morbid obesity. Surgical Endoscopy 2006 20 859-863. (doi:10.1007/s00464-005-0134-5)
31. Granada ML, Ulied A, Casanueva FF, Pico A, Lucas T, Torres E & Sanmartí A. Serum IGF-1 measured by four different immunoassays in patients with adult GH deficiency or acromegaly and in a control population. Clinical Endocrinology 2008 68 942-950. (doi:10.1111/j.1365-2265.2007.03120.x)
32. Pellitero S, Olaizola I, Alastrue A, Martínez E, Granada ML, Balibrea JM, Moreno P, Serra A, Navarro-Díaz M, Romero R et al. Hypogonadotropic hypogonadism in morbidly obese males is reversed after bariatric surgery. Obesity Surgery 2012 25 1835-1842. (doi:10.1007/s11695-012- 0734-9)
33. Padwal R, Klarenbach S, Wiebe N, Hazel M, Birch D, Karmali S, Sharma AM, Manns B & Tonelli M. Bariatric surgery: a systematic review and network meta-analysis of randomized trials. Obesity Reviews 2011 12 602-621. (doi:10.1111/j.1467-789X.2011.00866.x)
34. Gehrer S, Kern B, Peters T, Christoffel-Courtin C & Peterli R. Fewer nutrient deficiencies after laparoscopic sleeve gastrectomy (LSG) than after laparoscopic Roux-Y-gastric bypass (LRYGB) - a prospective study. Obesity Surgery 2010 20 447-453. (doi:10.1007/s11695-009-0068-4)
35. Peterli R, Steinert RE, Woelnerhanssen B, Peters T, Christoffel- Courtin C, Gass M, Kern B, von Fluee M & Beglinger C. Metabolic and hormonal changes after laparoscopic Roux-en-Y gastric bypass and sleeve gastrectomy: a randomized, prospective trial. Obesity Surgery 2012 22 740-748. (doi:10.1007/s11695-012-0622-3)
36. Don BR & Kaysen G. Poor nutritional status and inflammation: serum albumin: relationship to inflammation and nutrition. Seminars in Dialysis 2004 17 432-437. (doi:10.1111/j.0894-0959.2004.17603.x)
37. Holdstock C, Engström BE, Ohrvall M, Lind L, Sundbom M & Karlsson FA. Ghrelin and adipose tissue regulatory peptides: effect of gastric bypass surgery in obese humans. Journal of Clinical Endocrinology and Metabolism 2003 88 3177-3183. (doi:10.1210/jc.2002-021734)
38. Pérez-Romero N, Serra A, Granada ML, Rull M, Alastrué A, Navarro-Díaz M, Romero R & Fernández- Llamazares J. Effects of two variants of Roux-en-Y gastric bypass on metabolism behaviour: focus on plasma ghrelin concentrations over a 2-year follow-up. Obesity Surgery 2010 20 600-609. (doi:10.1007/s11695-009-0035-0)
39. Cummings DE, Weigle DS, Frayo RS, Breen PA, Ma MK, Dellinger EP & Purnell JQ. Plasma ghrelin levels after diet-induced weight loss or gastric bypass surgery. New England Journal of Medicine 2002 23 1623-1630. (doi:10.1056/NEJMoa012908)
40. Chronaiou A, Tsoli M, Kehagias I, Leotsinidis M, Kalfarentzos F & Alexandrides TK. Lower ghrelin levels and exaggerated postprandial peptide-YY, glucagon-like peptide-1, and insulin responses, after gastric fundus resection, in patients undergoing Roux-en-Y gastric bypass: a randomized clinical trial. Obesity Surgery 2012 22 1761-1770. (doi:10.1007/s11695-012-0738-5)